Literature DB >> 3040886

Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

J H Kehrl, A Miller, A S Fauci.   

Abstract

In this study we demonstrate that the monocyte/macrophage product, tumor necrosis factor alpha (TNF-alpha), has significant in vitro effects of B cell function. It costimulated with anti-mu in the induction of B cell DNA synthesis, and it prolonged the DNA synthesis initiated in B cell cultures stimulated with the human B cell mitogen, Staphylococcus aureus Cowan strain I (SAC). The addition of either IL-1 or IFN-gamma to TNF-alpha resulted in a substantial further increase in DNA synthesis. The addition of TNF-alpha to IL-2, a known inducer of SAC-activated B cell Ig secretion, resulted in a twofold enhancement in the amount of IL-2 stimulated B cell Ig secretion. Receptor binding studies with 125I-TNF-alpha demonstrate a marked increase in TNF-alpha binding sites after B cell activation (approximately 6,000 sites per cell, with an apparent Kd of 2.0 X 10(-10) M). Thus, TNF-alpha may be an important factor in human B cell function and is likely to interact with other T cell and monocyte derived cytokines in the regulation of human B cell proliferation and Ig production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040886      PMCID: PMC2188695          DOI: 10.1084/jem.166.3.786

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  B cell growth factor activity of interferon-gamma. Recombinant human interferon-gamma promotes proliferation of anti-mu-activated human B lymphocytes.

Authors:  S Romagnani; M G Giudizi; R Biagiotti; F Almerigogna; C Mingari; E Maggi; C M Liang; L Moretta
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Serum containing endotoxin-induced tumour necrosis factor substitutes for helper T cells.

Authors:  M K Hoffmann; S Green; L J Old; H F Oettgen
Journal:  Nature       Date:  1976-09-30       Impact factor: 49.962

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF).

Authors:  A Muraguchi; A S Fauci
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

6.  Macrophage factor controlling differentiation of B cells.

Authors:  M K Hoffmann; S Koenig; R S Mittler; H F Oettgen; P Ralph; C Galanos; U Hammerling
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

7.  The effects of interleukin 1 on human B cell activation and proliferation.

Authors:  R J Falkoff; A Muraguchi; J X Hong; J L Butler; C A Dinarello; A S Fauci
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

Authors:  B J Sugarman; B B Aggarwal; P E Hass; I S Figari; M A Palladino; H M Shepard
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

10.  Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Authors:  J Vilcek; V J Palombella; D Henriksen-DeStefano; C Swenson; R Feinman; M Hirai; M Tsujimoto
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  59 in total

Review 1.  Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.

Authors:  P F Piguet
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Control of humoral immune responses by arachidonic acid metabolites.

Authors:  T W Behrens; J S Goodwin
Journal:  Agents Actions       Date:  1989-01

Review 3.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha.

Authors:  B Ryffel; M Brockhaus; U Dürmüller; F Gudat
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

5.  Effect of recombinant human tumour necrosis factor beta (TNF beta) on activation, proliferation and differentiation of human B lymphocytes.

Authors:  H Zola; A Nikoloutsopoulos
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  Tumour necrosis factor receptor distribution in human lymphoid tissue.

Authors:  B Ryffel; M Brockhaus; B Greiner; M J Mihatsch; F Gudat
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

Review 7.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

8.  Household endotoxin levels and the risk of non-Hodgkin lymphoma.

Authors:  Jun Wang; Wendy Cozen; Peter S Thorne; Kiros Berhane; James R Cerhan; Patricia Hartge; Mary H Ward; Anneclaire J De Roos; Richard K Severson; Lindsay M Morton; Leslie Bernstein; Martha S Linet; Joanne S Colt
Journal:  Cancer Causes Control       Date:  2013-01-01       Impact factor: 2.506

9.  Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.

Authors:  R Landmann; U Keilholz; C Scheibenbogen; M Brockhaus; H Gallati; H Denz; M Bargetzi; C Ludwig
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

10.  Differential effect of tumour necrosis factor on human thymocyte subpopulations.

Authors:  M A Muñoz-Fernández; F X Pimentel-Muiños; A González; F Gambon; L Alvarez-Vallina; M Fresno
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.